Malaria Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country
Condition:   Malaria Interventions:   Biological: SumayaVac-1(SUM-101);   Biological: Verorab;   Biological: CHMI Sponsors:   Swiss Tropical & Public Health Institute;   Ifakara Health Institute;   Sumaya Biotech GmbH & Co. KG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials